1
A Study of Ve-VRD or S-VRD Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia
Condition(s):Plasma Cell LeukemiaLast Updated:May 23, 2023Recruiting
Leukemia, Plasma Cell: 692 Clinical Trials, Page 1 of 70
Hide Studies Not Open or Pending
2
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia
Condition(s):Plasma Cell LeukemiaLast Updated:August 8, 2023Recruiting
3
Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation
Condition(s):Plasma Cell LeukemiaLast Updated:September 23, 2021Not yet recruiting
4
Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell Leukemia
Condition(s):Plasma Cell LeukemiaLast Updated:December 19, 2018Withdrawn
5
Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia
Condition(s):Primary Plasma Cell LeukemiaLast Updated:March 14, 2012Completed
6
CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Condition(s):Multiple Myeloma; Plasma Cell LeukemiaLast Updated:April 20, 2023Recruiting
7
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Condition(s):Relapsed/Refractory Multiple Myeloma; Plasma Cell LeukemiaLast Updated:March 8, 2023Not yet recruiting
8
A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Condition(s):Relapsed/Refractory Multiple Myeloma; Plasma Cell LeukemiaLast Updated:May 24, 2022Recruiting
9
Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
Condition(s):Relapsed and/or Refractory Multiple Myeloma; Plasma Cell Leukemia in RelapseLast Updated:June 8, 2023Recruiting
10
Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70
Condition(s):Multiple MyelomaLast Updated:December 1, 2016Completed